hims and hers semaglutide & launches Wegovy knockoff pill, drugmaker Novo Nordisk vows to sue Hims & Hers falls 8%

Are NuScience COAs reliable

Within hours of the patent expiry of Ozempic on March 20, at least nine copycat versions of semaglutide were launched, signalling what could become the worlds most competitive and affordable market for blockbuster obesity and diabetes drugs

In the revenue numbers, this isnt fully visible yet due to extremely strong market growth (which means Novos turnover was still growing in Q2 2025)

Because some of the drug from week 1 is still present in week 2 (and so on), it takes several dosing cycles for these levels to build up and stabilize

Medically reviewed Reviewed by Dr

Body weight, health condition, and diet determine how much of a supplement to take